Oxford COVID-19 vaccine 95% effective if given 3 months apart, says SII's Adar Poonawalla
British-Swedish pharma giant AstraZeneca Plc will soon come out with data manifesting that the efficacy of its coronavirus vaccine rises to as much as 95 per cent if the two shots are parted by around 2-3 months, said Adar Poonawalla, Chief Executive Officer, Serum Institute of India (SII).
¤Ñ¤Ñ
Serum Institute of India (SII)ÀÇ CEO ÀÎ Adar Poonawalla´Â 12 ¿ù 28 ÀÏ ¹é½ÅÀÌ ¿µ±¹ ÀǾàÇ° ¹× ÀÇ·á Á¦Ç° ±ÔÁ¦ ±â°ü°ú Àεµ ±ÔÁ¦ ±â°üÀÎ ÀεµÀÇ ÀǾàÇ° ÄÁÆ®·Ñ·¯ Ãѵ¶ (DCGI)À¸·ÎºÎÅÍ ÀÀ±Þ »ç¿ë Çã°¡¸¦, 1 ¿ù ÃʱîÁö ¹ÞÀ»°ÍÀ̶ó°í ¹àÈû
¾Æ½ºÆ®·ÎÁ¦³×Ä« Äڷγª ¹ÙÀÌ·¯½º ¹é½ÅÀÇ È¿´ÉÀÌ 2 ~ 3 °³¿ù Á¤µµ ºÐ¸® Åõ¿©µÇ¸é 95 %±îÁö »ó½ÂÇÑ´Ù´Â µ¥ÀÌÅ͸¦ ¹ßÇ¥ ÇÒ °ÍÀ̶ó°í SII CEO ÀÎ Adar Poonawalla´Â ¸»Çß½À´Ï´Ù.
¤Ñ¤Ñ¤Ñ
ÁøÂ¥ ½Â¸® °ø½Ä¹ß°ßÇß³ªº½
±â´ëµÇ³×¿ä
|
ÁÁÀº ¼Ò½ÄÀ̳׿ä
´ëºÎºÐ ÀÌ°Å ¸Â°ÔµÉ°Å°°Àºµ¥ È¿°ú°¡ ³ô¾Æ¾ß °ÚÁÒ